CJC1295 + Ipamorelin 10 mg

CJC-1295 + Ipamorelin is a research blend that pairs two distinct growth hormone secretagogue peptides commonly studied together in preclinical models of the somatotropic axis. CJC-1295 (here the "without DAC" form, also called Modified GRF 1-29) is a synthetic 29-amino-acid analog of growth hormone-releasing hormone (GHRH) carrying stabilizing residue substitutions that extend its half-life relative to native GHRH. Ipamorelin is a synthetic pentapeptide (sequence Aib-His-D-2Nal-D-Phe-Lys-NH2) classified as a ghrelin/growth hormone secretagogue receptor (GHS-R1a) agonist. The two molecules are combined because they act on separate receptor pathways.

In preclinical and in-vitro research, CJC-1295 has been investigated for its role in binding the GHRH receptor on pituitary somatotrophs to stimulate cAMP-dependent synthesis and release of growth hormone, reportedly while preserving pulsatile secretion patterns in animal models. Ipamorelin has been studied as a highly selective GHS-R1a agonist that, in animal studies, raised plasma growth hormone with minimal observed effect on cortisol, prolactin, or ACTH compared with earlier GHRP compounds. Investigators have examined the combination because simultaneous activation of the GHRH and ghrelin receptor pathways has been reported to produce a synergistic growth hormone response greater than either peptide alone, making the blend a frequent tool in studies of GH regulation, body-composition models, and somatotropic signaling. All described effects derive strictly from laboratory and animal research and are not claims of human efficacy.

Specifications: CJC-1295 (without DAC) CAS 863288-34-0 · Molecular formula C152H252N44O42 (PubChem CID 91976842) · 29 amino acids · Ipamorelin CAS 170851-70-4 · Molecular formula C38H49N9O5 (PubChem CID 9831659) · Molecular weight approx. 711.9 g/mol · 5 amino acids · Total peptide content 10 mg · Purity >=99% (HPLC) · Form lyophilized powder · Available sizes Default

Storage & handling: Store the lyophilized powder at -20C and protect from light. Reconstitute with bacteriostatic (BAC) water; keep the reconstituted solution refrigerated and use within a few weeks. Avoid repeated freeze-thaw cycles.

For research use only. Not for human consumption. This product is not a drug, food, or dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease.